A Phase 2, Placebo-Controlled Study of the Opioid Receptor Antagonist LY2196044 for the Treatment of Alcohol Dependence

Conrad J. Wong, Jennifer Witcher, Craig Mallinckrodt, Robert A. Dean, Raymond F. Anton, Yunfei Chen, Bonnie A. Fijal, Haojun Ouyang, Sweta Dharia, Scott S. Sundseth, Kory J. Schuh, Bruce J. Kinon

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase 2, Placebo-Controlled Study of the Opioid Receptor Antagonist LY2196044 for the Treatment of Alcohol Dependence'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences